全文获取类型
收费全文 | 10176篇 |
免费 | 552篇 |
国内免费 | 290篇 |
学科分类
医药卫生 | 11018篇 |
出版年
2023年 | 91篇 |
2022年 | 158篇 |
2021年 | 295篇 |
2020年 | 229篇 |
2019年 | 230篇 |
2018年 | 208篇 |
2017年 | 251篇 |
2016年 | 311篇 |
2015年 | 331篇 |
2014年 | 524篇 |
2013年 | 706篇 |
2012年 | 502篇 |
2011年 | 620篇 |
2010年 | 459篇 |
2009年 | 496篇 |
2008年 | 530篇 |
2007年 | 565篇 |
2006年 | 493篇 |
2005年 | 405篇 |
2004年 | 355篇 |
2003年 | 319篇 |
2002年 | 263篇 |
2001年 | 241篇 |
2000年 | 242篇 |
1999年 | 182篇 |
1998年 | 181篇 |
1997年 | 170篇 |
1996年 | 147篇 |
1995年 | 151篇 |
1994年 | 148篇 |
1993年 | 132篇 |
1992年 | 92篇 |
1991年 | 136篇 |
1990年 | 100篇 |
1989年 | 82篇 |
1988年 | 76篇 |
1987年 | 67篇 |
1986年 | 67篇 |
1985年 | 69篇 |
1984年 | 67篇 |
1983年 | 26篇 |
1982年 | 36篇 |
1981年 | 38篇 |
1980年 | 34篇 |
1979年 | 33篇 |
1978年 | 22篇 |
1977年 | 22篇 |
1976年 | 24篇 |
1973年 | 15篇 |
1972年 | 18篇 |
排序方式: 共有10000条查询结果,搜索用时 156 毫秒
1.
2.
《Journal of vascular surgery》2020,71(6):1921-1929
ObjectiveIdentifying biomarkers for abdominal aortic aneurysms (AAA) could prove beneficial in prognosis of AAA and thus the selection for treatment. Microfibrillar-associated protein 4 (MFAP4) is an extracellular matrix protein that is highly expressed in aorta. MFAP4 is involved in several tissue remodeling-related diseases. We aimed to investigate the potential role of plasma MFAP4 (pMFAP4) as a biomarker of AAA.MethodsPlasma samples and data were obtained for 504 male AAA patients and 188 controls in the Viborg Vascular (VIVA) screening trial. The pMFAP4 levels were measured by Alphalisa. The Mann-Whitney U test assessed differences in pMFAP4 levels between the presence and absence of different exposures of interest. The correlation between pMFAP4 and aorta growth rate were investigated through spearman's correlation analysis. Immunohistochemistry and multiple logistic regression adjusted for potential confounders assessed the association between pMFAP4 and AAA. Multiple linear regression assessed the correlation between pMFAP4 and aorta growth rate. Cox regression and competing risk regression were used to investigate the correlation between AAA patients with upper tertile pMFAP4 and the risk of undergoing later surgical repair.ResultsA significant negative correlation between pMFAP4 and aorta growth rate was observed using spearman's correlation analysis (ρ = −0.14; P = .0074). However, this finding did not reach significance when applying multiple linear regression. A tendency of decreased pMFAP4 was observed in AAA using immunohistochemistry. Competing risk regression adjusted for potential confounders indicated that patients with upper tertile pMFAP4 had a hazard ratio of 0.51 (P = .001) for risk of undergoing later surgical repair.ConclusionsHigh levels of pMFAP4 are associated with a decreased likelihood of receiving surgical repair in AAA. This observation warrants confirmation in an independent cohort. 相似文献
3.
4.
Very preterm children are at increased risk of reduced processing speed at 5 years of age,predicted by typical complications of prematurity and prenatal smoking 下载免费PDF全文
5.
6.
《Gait & posture》2019
BackgroundThere is a clinical need to be able to reliably detect meaningful changes (0.1 to 0.2 m/s) in usual gait speed (UGS) considering reduced gait speed is associated with morbidity and mortality.Research questionWhat is the impact of tester on UGS assessment, and the influence of test repetition (trial 1 vs. 2), timing method (manual stopwatch vs. automated timing), and starting condition (stationary vs. dynamic start) on the ability to detect changes in UGS and fast gait speed (FGS)?MethodsUGS and FGS was assessed in 725 participants on a 8-m course with infrared timing gates positioned at 0, 2, 4 and 6 m. Testing was performed by one of 13 testers trained by a single researcher. Time to walk 4-m from a stationary start (i.e. from 0-m to 4-m) was measured manually using a stopwatch and automatically via the timing gates at 0-m and 4-m. Time taken to walk 4-m with a dynamic start was measured during the same trial by recording the time to walk between the timing gates at 2-m and 6-m (i.e. after 2-m acceleration).ResultsTesters differed for UGS measured using manual vs. automated timing (p = 0.02), with five and two testers recording slower and faster UGS using manual timing, respectively. 95% limits of agreement for trial 1 vs. 2, manual vs. automated timing, and dynamic vs. stationary start ranged from ±0.15 m/s to ±0.20 m/s, coinciding with the range for a clinically meaningful change. Limits of agreement for FGS were larger ranging from ±0.26 m/s to ±0.35 m/s.SignificanceRepeat testing of UGS should performed by the same tester or using an automated timing method to control for tester effects. Test protocol should remain constant both between and within participants as protocol deviations may result in detection of an artificial clinically meaningful change. 相似文献
7.
《Biomaterials》2015
Tenocytes represent a valuable source of cells for the purposes of tendon tissue engineering and regenerative medicine and as such, should possess a high degree of tenogenic differentiation prior to their use in vivo in order to achieve maximal efficacy. In the current report, we identify an efficient means by which to maintain differentiated tenocytes in vitro by employing the hanging drop technique in combination with defined growth media supplements. Equine tenocytes retained a more differentiated state when cultured as scaffold-free microtissue spheroids in low serum-containing medium supplemented with l-ascorbic acid 2-phosphate, insulin and transforming growth factor (TGF)-β1. This was made evident by significant increases in the expression levels of pro-tenogenic markers collagen type I (COL1A2), collagen type III (COL3A1), scleraxis (SCX) and tenomodulin (TNMD), as well as by enhanced levels of collagen type I and tenomodulin protein. Furthermore, tenocytes cultured under these conditions demonstrated a typical spindle-like morphology and when embedded in collagen gels, became highly aligned with respect to the orientation of the collagen structure following their migration out from the microtissue spheroids. Our findings therefore provide evidence to support the use of a biomimetic microtissue approach to culturing tenocytes and that in combination with the defined growth media described, can improve their differentiation status and functional repopulation of collagen matrix. 相似文献
8.
L. L. Morselli L. Manetti C. Cosci C. Sardella F. Bogazzi C. Faldini E. Martino M. Gasperi 《Journal of orthopaedics and traumatology》2006,7(4):169-175
Growth hormone (GH) is fundamental for the maintenance of bone mass and metabolism both during childhood and in adulthood.
This effect is due to a complex interaction between circulating GH and IGF-I produced peripherally. In vitro data and experimental
animal models have clarified many of the regulatory mechanisms underlying the characteristic skeletal changes occurring in
acromegaly. This review focuses on the effects of GH excess on bone metabolism and mass in acromegalic patients and, in particular,
on the influence of factors such as hypogonadism, gender, age and therapy on bone metabolism and arthropathy. 相似文献
9.
人胶质瘤干细胞内在自我更新能力 总被引:1,自引:1,他引:0
目的 了解胶质瘤干细胞内在的自我更新和增殖能力。方法 观察原代胶质瘤细胞在单纯改良Eagle/F12培养液(DMEM/F12)中胶质瘤干细胞球的形成,并检测其CD133、胶质纤维酸性蛋白(GFAP)、微管相关蛋白(MAP2)、髓磷脂碱性蛋白(MBP)的表达。通过二代球体形成、细胞增殖测定、分化实验分析其自我更新、增殖、多能分化能力。通过裸鼠移植瘤实验观察所分离细胞球细胞与原代培养胶质瘤细胞成瘤能力的差异。结果 在单纯DMEM/F12培养液中形成的胶质瘤细胞球细胞表达神经干细胞标记CD133,不表达分化标志GFAP、MAP2,少数细胞表达MBP。分离出的胶质瘤细胞球细胞可在单纯DMEM/F12培养基中增殖,并能形成CD133阳性的二代细胞球,可分化为GFAP、MAP2、MBP阳性表达的肿瘤细胞。裸鼠成瘤实验显示其成瘤能力显著高于原代胶质瘤细胞。结论 胶质瘤干细胞能在无血清、无外源性细胞因子培养基中形成肿瘤干细胞球,胶质瘤干细胞的自我更新和增殖不依赖于外源性生长因子,它可能拥有自我更新的自身活化机制。 相似文献
10.